Healthcare Market Research Reports & Industry Analysis
MarketResearch.com provides detailed reports for various countries around the world and the healthcare needs and offerings in those countries. These reports also profile the types of administrations and regulations and policies that are in place in various regions and segments in each country.
Reports are available in industry sub-categories such as: wellness and preventative programming, sports medicine, insurance and managed care, and clinical guidelines and best practices. Readers may also find data regarding alternative and complementary medicine, nursing, public health and information technology. Though not always considered when first thinking of healthcare, information may also be found on veterinary health.
Reviews of various equipment and pharmaceuticals in specific regions are made available regarding multiple countries. Herbal and traditional products are contrasted and compared, and global access to sufficient ambulance services is discussed.
Healthcare Industry Research & Market Reports
-
Jordan Pharmaceuticals & Healthcare Q2 2019
... market in Denmark remains broadly positive, withrobust gains in the large non-hydropower renewable energy sector more than compensating for a decline in output from thermalpower sources, as showcase by a successful energy auction in December ... Read More
-
Malaysia Pharmaceuticals & Healthcare Q2 2019
... market in Denmark remains broadly positive, withrobust gains in the large non-hydropower renewable energy sector more than compensating for a decline in output from thermalpower sources, as showcase by a successful energy auction in December ... Read More
-
New Zealand Pharmaceuticals & Healthcare Q2 2019
... power market in Denmark remains broadly positive, withrobust gains in the large non-hydropower renewable energy sector more than compensating for a decline in output from thermalpower sources, as showcase by a successful energy auction in ... Read More
-
Cambodia Pharmaceuticals & Healthcare Q2 2019
... Low-cost, generic medicines will continue to account for most of the market,given low affordability levels. Pharmaceutical companies operating in the country will continue to face challenges stemming frompoor access to health service and counterfeit medicines. Read More
-
Japan Pharmaceuticals & Healthcare Q2 2019
... market in Denmark remains broadly positive, withrobust gains in the large non-hydropower renewable energy sector more than compensating for a decline in output from thermalpower sources, as showcase by a successful energy auction in December ... Read More
-
Mozambique Pharmaceuticals & Healthcare Q2 2019
... market in Denmark remains broadly positive, withrobust gains in the large non-hydropower renewable energy sector more than compensating for a decline in output from thermalpower sources, as showcase by a successful energy auction in December ... Read More
-
Ecuador Pharmaceuticals & Healthcare Q2 2019
... market in Denmark remains broadly positive, withrobust gains in the large non-hydropower renewable energy sector more than compensating for a decline in output from thermalpower sources, as showcase by a successful energy auction in December ... Read More
-
Georgia Pharmaceuticals & Healthcare Q2 2019
... market in Denmark remains broadly positive, withrobust gains in the large non-hydropower renewable energy sector more than compensating for a decline in output from thermalpower sources, as showcase by a successful energy auction in December ... Read More
-
Belarus Pharmaceuticals & Healthcare Q2 2019
... pricing methodology will improve transparency of the market,but may also result in downward pressure on drug prices. In the meantime, the country's domestic pharmaceutical industrycontinues to expand rapidly, driven by contract manufacturing agreements and joint ... Read More
-
Morocco Pharmaceuticals & Healthcare Q2 2019
... market in Denmark remains broadly positive, withrobust gains in the large non-hydropower renewable energy sector more than compensating for a decline in output from thermalpower sources, as showcase by a successful energy auction in December ... Read More
-
Armenia Pharmaceuticals & Healthcare Q2 2019
... country's pharmaceutical expenditure. Public healthcarefunding is set to increase in 2019 by almost 10% y-o-y, bolstered by economic growth that, although is likely to be moderated bythe slowing momentum of Russia's economic recovery, will remain ... Read More
-
Namibia Pharmaceuticals & Healthcare Q2 2019
... market in Denmark remains broadly positive, withrobust gains in the large non-hydropower renewable energy sector more than compensating for a decline in output from thermalpower sources, as showcase by a successful energy auction in December ... Read More
-
Austria Pharmaceuticals & Healthcare Q2 2019
... sizecompared to its EU partners. However, like its eurozone neighbours, we believe Austria's pharmaceutical spending will be subduedover the medium term, as states scramble to contain rising pharmaceutical expenditure in line with increasing healthcare demands. Read More
-
Laos Pharmaceuticals & Healthcare Q2 2019
... market in Denmark remains broadly positive, withrobust gains in the large non-hydropower renewable energy sector more than compensating for a decline in output from thermalpower sources, as showcase by a successful energy auction in December ... Read More
-
Tanzania Pharmaceuticals & Healthcare Q2 2019
... market in Denmark remains broadly positive, withrobust gains in the large non-hydropower renewable energy sector more than compensating for a decline in output from thermalpower sources, as showcase by a successful energy auction in December ... Read More
-
Argentina Pharmaceuticals & Healthcare Q2 2019
... investment in thehealthcare sector and a growing prevalence of non-communicable diseases among the population. However, the governmentcontinues to face a constrained fiscal situation that we expect to lead to further scrutiny of pharmaceutical pricing andreimbursement. Read More
-
Iran Pharmaceuticals & Healthcare Q2 2019
... market in Denmark remains broadly positive, withrobust gains in the large non-hydropower renewable energy sector more than compensating for a decline in output from thermalpower sources, as showcase by a successful energy auction in December ... Read More
-
Romania Pharmaceuticals & Healthcare Q2 2019
... market in Denmark remains broadly positive, withrobust gains in the large non-hydropower renewable energy sector more than compensating for a decline in output from thermalpower sources, as showcase by a successful energy auction in December ... Read More
-
Azerbaijan Pharmaceuticals & Healthcare Q2 2019
... the authorities reportedly to allocate considerable funds specifically for this purpose.Nevertheless, the Azerbaijan's pharmaceutical and healthcare markets will remain only of marginal interest to multinationals, giventhe population's reliance on out-of-pocket payments, and thus the preference ... Read More
-
Memorial Health System - Strategic SWOT Analysis Review
... key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope ... Read More
-
Sentara Healthcare Inc - Strategic SWOT Analysis Review
... key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope ... Read More
-
Oman Pharmaceuticals & Healthcare Q2 2019
... regulations in the Gulf Cooperation Council region willgo some way to alleviating the drawback of Oman's small market size. However, the government continues to face a constrainedfiscal situation that we expect to lead to further ... Read More
-
United States Pharmaceuticals & Healthcare Q2 2019
... Other leadingtherapy areas include immunology, vaccines and dermatology. Focused firms with mega-blockbusters are outperforming morediversified drugmakers with broad portfolios. Innovative companies with established medicine businesses are being impacted bygeneric drug pricing pressures in the US. Read More
-
Qatar Pharmaceuticals & Healthcare Q2 2019
... market growth rates. Free-zones and government incentives to attract pharmaceutical companies to set up in the country will create a good opportunity fordrugmakers, although this will remain counterbalanced by regional political instability and Qatar’s small ... Read More
-
Saudi Arabia Pharmaceuticals & Healthcare Q2 2019
... the market, with ‘Vision 2030’encouraging the expansion of manufacturing agreements in the country. Positive market drivers, such as the rising burden ofchronic disease and the increasing privatisation of the healthcare system, will ensure robust long-term ... Read More
